Dafalgan Direct, Schmelztabletten

7680551380016 CH-55138 Schmelztabletten
Dafalgan Direct, Schmelztabletten
Dafalgan Direct, Schmelztabletten
1 / 2
google

Article details

Package size
16
Selling units
16
Measure
Tablette(n)
Galenic form
Schmelztabletten
Galenic group
Lutschtabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
06/05/2025
Patient information leaflet
Français
06/05/2025
Patient information leaflet
Italien
06/05/2025
Summary of Product Characteristics
Allemand
06/05/2025
Summary of Product Characteristics
Français
06/05/2025
Summary of Product Characteristics
Italien
06/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
500.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
30.5 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
25.0 MG Substance HBESI
(N/A)
4.8 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
39.0 MG Substance HBESI

Authorization holder

UPSA Switzerland AG

6300 Zug

Authorization information

Swissmedic authorization number
55138
Drug name
Dafalgan Direct, Schmelztabletten
Galenic form
SCHM
ATC Code
N02BE01
Authorization status
Z
Dispensing category
D
First authorization
27/02/2002
Authorization expiration date
31/12/9999
IT Number
01.01.1.
Domain
Human medicine
Field of application
Analgetikum, Antipyretikum

Package details

Description (FR)
DAFALGAN Direct cpr orodisp 500 mg bte 16 pce
Description (DE)
DAFALGAN Direct Schmelztabl 500 mg Ds 16 Stk
Market launch
18/10/2013
Narcotic (BTM)
No

Other package sizes (2)

None
16 TABL
GTIN: None
Not in V1
DAFALGAN ODIS cpr orodisp 500 mg bte 16 pce
None None
GTIN: 7680551380047
Not in V1